Bundesverband der Arzneimittel-Hersteller e.V.

Tweet this page
Registration as it was on 27 Oct 2022
How to read and use this data card.
Download this datacard


Lobbying Costs

100,000€ - 199,999€

Financial year: Jan 2021 - Dec 2021

Lobbyists (Full time equivalent)

3.5 Fte (6)

Lobbyists with EP accreditation


High-level Commission meetings


Lobbying Costs over the years

  • Info

    Bundesverband der Arzneimittel-Hersteller e.V.   (BAH)

    EU Transparency Register

    945120918083-26 First registered on 06 Jul 2015

    Goals / Remit

    The Bundesverband der Arzneimittel-Hersteller e.V. (BAH), the German Medicines Manufacturers‘ Association, represents the interests of the pharmaceutical industry in Germany comprising international companies as well as local small and medium enterprises (SME). By company membership BAH is the leading trade organisation of the pharmaceutical industry in Germany.

    BAH covers the entire range of the industrial landscape from self-medication medicines (OTC) through to prescription drugs (Rx), substance based medical devices as well as digital health applications.

    BAH advocates for secure and responsible self-medication through professional medical and pharmaceutical advice.

    BAH is committed to free, fair and clean advertising and promotes these principles through its registered society INTEGRITAS.

    BAH actively takes part in public health policy discussion.

    Main EU files targeted

    - EU Pharmaceutical Strategy
    - Revision of the general pharmaceutical legislation
    - Revision on EU legislation on medicines for children and for rare diseases
    - Revision of the legislation on supplementary protection certificates (SPCs)
    - Health Technology Assessment
    - Falsified Medicines Directive
    - Pharmacovigilance framework
    - Clinical Trials Regulation
    - Sustainability & Pharmaceuticals in the environment
    - Health Claims Regulation
    - Interlectual Property
    - European Health Data Space
    - Brexit Implementation
    - EMA Mandate
    - European Health Emergency Preparedness and Response Authority (HERA)
    - Artifical Intelligence
    - Implementation of Medical Device Directive


    Head Office
    Ubierstr. 71-73
    Bonn 53173
    EU Office
    Ubierstr. 71-73
    Bonn 53173


  • People

    Total lobbyists declared


    Employment timeLobbyists

    Lobbyists (Full time equivalent)


    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    2 accreditations were / are live (in bold) for the selected state of 29 Sep 2023

    Name Start date End Date
    Ms Anna WEHAGE 09 Sep 2023 06 Sep 2024
    Mr Hubertus CRANZ 09 Sep 2023 06 Sep 2024
    Ms Anna WEHAGE 29 Oct 2022 09 Sep 2023
    Mr Hubertus CRANZ 18 Oct 2022 09 Sep 2023
    Ms Anna WEHAGE 30 Oct 2021 29 Oct 2022
    Ms Wehage ANNA 30 Oct 2021 10 Jun 2022
    Mr Hubertus CRANZ 30 Oct 2021 18 Oct 2022
    Mr Hubertus CRANZ 26 Aug 2020 26 Aug 2021
    Ms Nadine NÖLTE 13 Feb 2020 01 Mar 2021
    Ms Susan KAFFENBERGER 22 Jan 2020 07 Oct 2020
    Mr Hubertus CRANZ, DR. 14 Jun 2019 01 Jul 2020
    Mr Dr Martin WEISER 10 Nov 2018 14 Jun 2019
    Ms Susan KAFFENBERGER 10 Nov 2018 09 Nov 2019
    Mr Johannes KOCH 30 Jan 2018 02 Nov 2018
    Mr Johannes KOCH 23 Jan 2017 10 Jan 2018
    Mr Johannes KOCH 04 Aug 2015 30 Jul 2016

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories


    Trade and business associations

  • Networking


    European Medicines Manufacturers Association AESGP

    Lebensmittelverband Deutschland

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2021 - Dec 2021

    Lobbying costs for closed financial year

    100,000€ - 199,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    100,000€ - 199,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)


    Groups (European Parliament)


    Other activities

    None declared

  • Meetings


    1 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't publish information about such meetings. All information below comes from European Commission web pages.

    • Date 30 Nov 2020 Location Online
      Subject Future of Medicines
      Cabinet Cabinet of Vice-President Margaritis Schinas
      Portfolio Promoting the European Way of Life
      • Maria Luisa Llano Cardenal (Cabinet member)
      • Margaritis Schinas (Vice-President)
Download this datacard